Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894)
Home
Publications
P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894)
P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894)
Authors:
GL
Gilberto De Lima Lopes
Gilberto De Lima Lopes
YW
Yi-Long Wu
Yi-Long Wu
SS
Sara Sadowski
Sara Sadowski
JZ
Jin Zhang
Jin Zhang
RR
Reshma Rangwala
Reshma Rangwala
DK
Debra Kush
Debra Kush
TM
Tony Mok
Tony Mok
Citation Alert
Add to Library
Cite
Download
Share
Download
Publisher website
Google Scholar
1 October 2016
journal article
Published by
Elsevier
in
Journal of Thoracic Oncology
Vol. 11
(10)
,
S244-S245
DOI:
10.1016/j.jtho.2016.08.114
Abstract
No abstract available
Cited
Cited by 15 articles
Scroll to top